Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000230112 refers to a pseudogene—a segment of DNA similar to part of the mitochondrial cytochrome c oxidase subunit III (MTCO3), but incorporated into the nuclear genome[1][4]. As a pseudogene, it is a non-functional remnant of a once-coding gene; it does not encode a functional protein and has no known direct biological function or disease association[1][4]. Pseudogenes like this, known as "nuclear mitochondrial DNA segments" (NUMTs), pose a notable challenge in molecular genetics, especially in DNA barcoding and genomic studies, because they can be mistakenly amplified instead of authentic mitochondrial genes, leading to erroneous interpretations[4]. ENSG00000230112 is not considered a therapeutic target, receptor, enzyme, transporter, or any other class of druggable target: it is non-functional and not implicated in any mechanism of action or biomarker strategy. This entry is correctly identified as a pseudogene, specifically a nuclear-embedded, non-functional copy of mitochondrial gene sequence (NUMT)[1][4]. It is not an active part of the electron transport chain (unlike the functional MTCO3 gene/protein)[2][3]. The record is included in genomic databases for annotation purposes, typically to prevent confusion in molecular/genetic analyses[1][4]. ENSG00000230112 is not a druggable or functional molecular target, but a non-functional nuclear pseudogene resembling part of cytochrome c oxidase subunit 3[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of cytochrome c oxidase subunit 3.